Parexel International Corp. (NASDAQ:PRXL)’s share price fell 2.7% during trading on Monday . The company traded as low as $63.69 and last traded at $64.12, with a volume of 377,460 shares traded. The stock had previously closed at $65.92.

A number of research firms have commented on PRXL. Avondale Partners decreased their price objective on shares of Parexel International Corp. from $50.50 to $49.00 and set an “underperform” rating for the company in a report on Monday, April 11th. William Blair downgraded shares of Parexel International Corp. from an “outperform” rating to a “market perform” rating in a report on Monday. Zacks Investment Research raised shares of Parexel International Corp. from a “hold” rating to a “strong-buy” rating and set a $75.00 price objective for the company in a report on Wednesday, April 13th. Citigroup Inc. reaffirmed a “buy” rating and issued a $74.00 price objective (up previously from $72.00) on shares of Parexel International Corp. in a report on Tuesday, July 5th. Finally, Evercore ISI raised shares of Parexel International Corp. from a “hold” rating to a “buy” rating in a report on Wednesday, June 1st. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $70.19.

The company has a market cap of $3.41 billion and a price-to-earnings ratio of 24.17. The firm’s 50 day moving average price is $61.96 and its 200 day moving average price is $62.16.

Parexel International Corp. (NASDAQ:PRXL) last issued its quarterly earnings results on Wednesday, April 27th. The company reported $0.89 EPS for the quarter, missing analysts’ consensus estimates of $0.90 by $0.01. The firm earned $527.10 million during the quarter, compared to the consensus estimate of $523.16 million. The firm’s revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.66 EPS. On average, equities analysts predict that Parexel International Corp. will post $3.42 EPS for the current year.

In other news, Director A Dana Callow, Jr. sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, June 13th. The stock was sold at an average price of $60.04, for a total transaction of $180,120.00. Following the completion of the transaction, the director now directly owns 34,072 shares in the company, valued at $2,045,682.88. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Ulf I. Schneider sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $59.24, for a total value of $473,920.00. Following the transaction, the senior vice president now owns 35,530 shares of the company’s stock, valued at $2,104,797.20. The disclosure for this sale can be found here.

Several hedge funds and institutional investors have modified their holdings of PRXL. New York State Common Retirement Fund raised its position in shares of Parexel International Corp. by 0.3% in the fourth quarter. New York State Common Retirement Fund now owns 76,563 shares of the company’s stock worth $5,215,000 after buying an additional 202 shares during the period. First Trust Advisors LP boosted its stake in Parexel International Corp. by 1.1% in the fourth quarter. First Trust Advisors LP now owns 21,598 shares of the company’s stock worth $1,471,000 after buying an additional 227 shares in the last quarter. Whittier Trust Co. boosted its stake in Parexel International Corp. by 1.1% in the fourth quarter. Whittier Trust Co. now owns 25,443 shares of the company’s stock worth $1,733,000 after buying an additional 265 shares in the last quarter. Rhumbline Advisers boosted its stake in Parexel International Corp. by 0.5% in the fourth quarter. Rhumbline Advisers now owns 112,400 shares of the company’s stock worth $7,657,000 after buying an additional 520 shares in the last quarter. Finally, I.G. Investment Management LTD. boosted its stake in Parexel International Corp. by 1.6% in the fourth quarter. I.G. Investment Management LTD. now owns 34,029 shares of the company’s stock worth $2,318,000 after buying an additional 545 shares in the last quarter.

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology and medical device industries across the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.